Hijery ny anatiny

Analyse coût-efficacité des alternatives à la transfusion sanguine

Hématologie

Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs. (manokatra rohy)

Beverina I, Razionale G, Ranzini M, Aloni A, Finazzi S, Brando B.

Loharanon-kevitra‎: Blood Transfus 2020;18(2):106-16.

Rakitra‎: PubMed 31855149

DOI‎: 10.2450/2019.0248-19

https://www.ncbi.nlm.nih.gov/pubmed/31855149 (manokatra rohy)

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. (manokatra rohy)

Deger M, Eisterer W, Kutikova L, Salek S.

Loharanon-kevitra‎: Support Care Cancer 2013;21(2):485-93.

Rakitra‎: PubMed 22825456

DOI‎: 10.1007/s00520-012-1538-0

https://www.ncbi.nlm.nih.gov/pubmed/22825456 (manokatra rohy)

Restrictive blood transfusion practices are associated with improved patient outcomes. (manokatra rohy)

Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, Shah N.

Loharanon-kevitra‎: Transfusion 2014;54(10 Pt 2):2753-9.

Rakitra‎: PubMed 24995770

DOI‎: 10.1111/trf.12723

https://www.ncbi.nlm.nih.gov/pubmed/24995770 (manokatra rohy)

Recombinant activated factor VII use in critically ill infants with active hemorrhage. (manokatra rohy)

Jen H, Shew S.

Loharanon-kevitra‎: J Pediatr Surg 2008;43(12):2235-8.

Rakitra‎: PubMed 19040942

DOI‎: 10.1016/j.jpedsurg.2008.08.053

https://www.ncbi.nlm.nih.gov/pubmed/19040942 (manokatra rohy)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (manokatra rohy)

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

Loharanon-kevitra‎: Blood Adv. 2022;6(3):785-92.

Rakitra‎: PubMed 34781363

DOI‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ (manokatra rohy)

Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation. (manokatra rohy)

Lightdale JR, Randolph AG, Tran CM, Jiang H, Colon A, Houlahan K, Billet A, Sloan S, Lehmann LE.

Loharanon-kevitra‎: Biol Blood Marrow Transplant 2012;18(5):813-7.

Rakitra‎: PubMed 22080050

DOI‎: 10.1016/j.bbmt.2011.10.043

https://www.ncbi.nlm.nih.gov/pubmed/22080050 (manokatra rohy)

The cost of blood: a study of the total cost of red blood cell transfusion in patients with β-thalassemia using time-driven activity-based costing. (manokatra rohy)

McQuilten ZK, Higgins AM, Burns K, Chunilal S, Dunstan T, Haysom HE, Kaplan Z, Rushford K, Saxby K, Tahiri R, Waters N, Wood EM.

Loharanon-kevitra‎: Transfusion 2019;59(11):3386-95.

Rakitra‎: PubMed 31664712

DOI‎: 10.1111/trf.15558

https://www.ncbi.nlm.nih.gov/pubmed/31664712 (manokatra rohy)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (manokatra rohy)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Loharanon-kevitra‎: Transfusion 2015;55(12):2807-15.

Rakitra‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (manokatra rohy)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (manokatra rohy)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Loharanon-kevitra‎: Cancer 2013;119(1):107-14.

Rakitra‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (manokatra rohy)

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (manokatra rohy)

Nikolaidi E, Hatzikou M, Geitona M.

Loharanon-kevitra‎: Cost Eff Resour Alloc 2013;11(1):16.

Rakitra‎: PubMed 23870502

DOI‎: 10.1186/1478-7547-11-16

https://www.ncbi.nlm.nih.gov/pubmed/23870502 (manokatra rohy)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (manokatra rohy)

Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT.

Loharanon-kevitra‎: Support Care Cancer 2012;20(1):159-65.

Rakitra‎: PubMed 21359879

DOI‎: 10.1007/s00520-010-1083-7

https://www.ncbi.nlm.nih.gov/pubmed/21359879 (manokatra rohy)

Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada. (manokatra rohy)

Pettigrew M, Garces K, Deuson R, Kassis J, Laroche V

Loharanon-kevitra‎: J Med Econ 2013;16(2):318-26.

Rakitra‎: PubMed 23216012

DOI‎: 10.3111/13696998.2012.756400

https://www.ncbi.nlm.nih.gov/pubmed/23216012 (manokatra rohy)

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (manokatra rohy)

Ravangard R, Mirzaei Z, Keshavarz K, Haghpanah S, Karimi M.

Loharanon-kevitra‎: Hematology 2018;23(7):417-22.

Rakitra‎: PubMed 29157136

DOI‎: 10.1080/10245332.2017.1404262

https://www.ncbi.nlm.nih.gov/pubmed/29157136 (manokatra rohy)

The burden of blood transfusion: a utilization and economic analysis--a pilot study in patients with chemotherapy-induced anemia (CIA). (manokatra rohy)

Reitan JF, Kudrik FJ, Fox K, van Breda A, Shreay S, Corey-Lisle PK.

Loharanon-kevitra‎: J Med Econ 2013;16(5):633-8.

Rakitra‎: PubMed 23425291

DOI‎: 10.3111/13696998.2013.778269

https://www.ncbi.nlm.nih.gov/pubmed/23425291 (manokatra rohy)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (manokatra rohy)

Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C.

Loharanon-kevitra‎: Transfusion 2010;50(2):487-92.

Rakitra‎: PubMed 19804569

DOI‎: 10.1111/j.1537-2995.2009.02413.x

https://www.ncbi.nlm.nih.gov/pubmed/19804569 (manokatra rohy)

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (manokatra rohy)

Stallworth JR, Jerrell JM, Tripathi A.

Loharanon-kevitra‎: Am J Hematol 2010;85(10):795-7.

Rakitra‎: PubMed 20645429

DOI‎: 10.1002/ajh.21772

https://www.ncbi.nlm.nih.gov/pubmed/20645429 (manokatra rohy)

Increased hospital costs associated with red blood cell transfusion. (manokatra rohy)

Trentino KM, Farmer SL, Swain SG, Burrows SA, Hofmann A, Ienco R, Pavey W, Daly FF, Van Niekerk A, Webb SA, Towler S, Leahy MF.

Loharanon-kevitra‎: Transfusion 2015;55(5):1082-9.

Rakitra‎: PubMed 25488623

DOI‎: 10.1111/trf.12958

https://www.ncbi.nlm.nih.gov/pubmed/25488623 (manokatra rohy)

ANALYSE COÛT-EFFICACITÉ DES ALTERNATIVES À LA TRANSFUSION SANGUINE
Hématologie
Malagasy
Hématologie
https://assetsnffrgf-a.akamaihd.net/assets/ct/ff2bd2cedc/images/syn_placeholder_sqr.png

Tompon’andraikitra eo An-toerana

Afaka miantso an’io sampan’asa io foana ny dokotera mitsabo Vavolombelon’i Jehovah, na andro na alina.

Adiresy sy Telefaonina

Fanazavana Momba ny Fitsaboana

Ireto avy no hita ato: Teknika fitsaboana tsy ampiasana ra rehefa very ra be na tsy ampy ra ilay marary, ny zavatra inoan’ny Vavolombelon’i Jehovah sy ny fitsaboana arahiny mifanaraka amin’izany, ary ny fanampiana omen’ny Vavolombelon’i Jehovah ny mpitsabo amin’ny alalan’ireo anisan’ny Komity Mifandray Amin’ny Hopitaly.

Zavatra Azo Alaina

Video

Izay azon’ny dokotera eritreretina sy isafidianana rehefa mitsabo Vavolombelon’i Jehovah.

Hijery Video